MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202617085929 A) filed by Hubei Bio-Pharmaceutical Industrial Technological on July 14, 2026, for Solid Dispersion Of P2x3 Receptor Antagonist And Preparation Process Thereof.
Inventors include Song, Haoyuan; Yang, Yiping; Cao, Xueteng; Huang, Xiang; Xu, Zebin; Hu, Hui; Jin, Ying; and Zhang, Bo.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: Provided is a solid dispersion containing a P2X3 receptor antagonist compound shown in formula I, which can increase the solubility of the compound shown in formula I, and improve the dissolution rate and bioavailability of the drug, ensuring the therapeutic effect of the drug. Meanwhile, the solid dispersion has good stability. During the storage process, the solid dispersion does not experience crystal form transformation and does not exhibit a significant increase in related substances, which improves the safety of the clinical use of the drug.
Disclaimer: Curated by HT Syndication.
